PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
Cell Reports · 2025-04 · 44 (4) · 115484
DOI: 10.1016/j.celrep.2025.115484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025-04. Verfasst von Qiaoxi Xia und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian 36…. Hauptthemen laut MEDLINE: Cisplatin, Ovarian Neoplasms, Protein-Arginine N-Methyltransferases, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.
- Department of Gynecology, Department of Obstetrics and Gynecology, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China.
- Department of Obstetrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen 361102, China.
- Medical Research Center, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518033, China.
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University; Shandong Key Laboratory of Reproductive Health and Birth Defects Prevention and Control, Jinan, Shandong 250012, China.
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University; Shandong Key Laboratory of Reproductive Health and Birth Defects Prevention and Control, Jinan, Shandong 250012, China. Electronic address:…
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Xiamen University
Zitieren
APA
Xia, Q., Zhong, R., Zheng, J., Zhou, X., Zhao, X., Wang, S., Wang, B., Wu, Q., Xie, C., Kong, B., Zhang, Q., & Huang, T. (2025). PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms. Cell Reports, 44(4), 115484. https://doi.org/10.1016/j.celrep.2025.115484
Vancouver
Xia Q, Zhong R, Zheng J, Zhou X, Zhao X, Wang S, et al. PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms. Cell Reports. 2025;44(4):115484. doi:10.1016/j.celrep.2025.115484
BibTeX
@article{Xia2025,
author = {Xia, Qiaoxi and Zhong, Ronghui and Zheng, Jingfang and Zhou, Xiao and Zhao, Xinwei and Wang, Sisi and Wang, Botao and Wu, Quanfeng and Xie, Chen and Kong, Beihua and Zhang, Qing and Huang, Tianzhi},
title = {PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms},
journal = {Cell Reports},
year = {2025},
volume = {44},
number = {4},
pages = {115484},
doi = {10.1016/j.celrep.2025.115484}
}
EUVIMED